InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Wadhane Jitendra. Director active across 1 company, notably Pyxis Oncology, Inc.. In total, 8 reports have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €17k. Activity tracked since 24 March 2023. The latest transaction was filed on 24 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Wadhane Jitendra is a declarant linked to Pyxis Oncology, Inc. on XNAS, where the listed company role is Prin Fin & Acct Officer. Across 8 total filings, the 8 sampled filings cover the period from 2023-03-28 to 2026-03-25, with EUR 16885 of buys and EUR 0 of sells, and the most common transaction nature is Attribution.